IUX made a notable impact at the Finance Magnates Africa Summit 2025 (FMAS:25) as a primary sponsor at the summit bar. The company not only stood out as a key participant but also created a dynamic atmosphere through its #DrinksOnIUX campaign. This initiative highlights IUX's commitment to expanding its presence and advancing digital trading solutions across the African region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2025070125...

The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts – early immune cell clonotypes critical in the formation of neutralizing antibodies – for measles, mumps and rubella. This effort aims to build the most comprehensive understanding of the formation of neutralizing antibodies to the vaccine and to identify the dominant and effective antibodies to these infe...

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a global pharmaceutical company focused on scientific and technological innovation, and Novaliq GmbH (“Novaliq”), a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, announce today that the China National Medical Products Administration (NMPA) has approved Heng Qin® (Perfluorohexyloctane Eye Drops) for the treatment of dry eye disease (DED) associated...